Stifel analyst Justin Keywood maintained a “Maintain” score on HLS Therapeutics (HLS Therapeutics Inventory Quote, Chart, Information, Analysts, Financials TSX:HLS) whereas reducing his goal worth to C$4.45 from C$4.75 following fourth-quarter outcomes that have been largely in keeping with expectations. In a March 12 report, Keywood stated HLS reported This fall income of US$15.2-million, barely above consensus […]
Supply
Elevate your perspective with NextTech Information, the place innovation meets perception.
Uncover the newest breakthroughs, get unique updates, and join with a worldwide community of future-focused thinkers.
Unlock tomorrow’s tendencies at this time: learn extra, subscribe to our publication, and change into a part of the NextTech group at NextTech-news.com
